Study Overview
Concise summary of objectives, hypothesis, design (randomized/controlled), primary and secondary endpoints, and trial phase, enabling rapid reviewer orientation and fit to sponsor or IRB requirements.
A well-structured proposal clarifies study purpose, demonstrates regulatory and ethical compliance, and reduces review cycles with IRBs and sponsors. Clear plans for safety, data integrity, and consent increase the likelihood of timely approval and protect participants and institutions.
Clinical investigators, study coordinators, research compliance officers, and sponsor clinical teams commonly prepare proposals for IRB and sponsor review.
Concise summary of objectives, hypothesis, design (randomized/controlled), primary and secondary endpoints, and trial phase, enabling rapid reviewer orientation and fit to sponsor or IRB requirements.
Detailed inclusion and exclusion criteria, screening procedures, and justification for chosen population to ensure consistent enrollment and minimize safety risks across sites.
Visit schedule, interventions, dosing, specimen collection, imaging and assessments with timing windows, allowing evaluators to judge feasibility and burden on participants.
Adverse event reporting plan, data and safety monitoring board (DSMB) arrangements if applicable, stopping rules, and plans for expedited reporting to regulatory bodies.
Data collection methods, case report form structure, validation rules, de-identification approach, and plans for secure storage and audit trails to preserve integrity and reproducibility.
Draft informed consent form language, HIPAA authorization where required, and procedures for documenting consent and protecting participant PHI throughout the study.
| Field | Configuration |
|---|---|
| Routing Order | Define signer and reviewer sequence for approvals |
| Required Fields | Mark essential fields as mandatory to prevent incomplete submissions |
| Authentication | Select signer verification method (email, SMS, KBA) |
| Audit Trail | Enable timestamping and action history for all participants |
Use secure digital channels with audit trails and access controls when sharing proposals and consent documents across organizations.
Choose platforms that integrate with clinical systems and support PHI protections consistent with HIPAA and institutional policies.
Standard board meetings may require 2–6 weeks for full-board review
Minimal-risk protocols may be reviewed in 1–2 weeks
Sponsor internal review cycles often range from 1–4 weeks
Agency queries may add 30–90 days depending on complexity
Site initiation visits and contracts may take 4–12 weeks
An investigator streamlined consent collection across clinics using an e-sign workflow
A research office standardized submission templates for multicenter trials
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | No | No | Yes, limited | Yes, limited |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |